ArticleEClinicalMedicine2024

Characterization of second primary malignancies post CAR T-cell therapy: real-world insights from the two global pharmacovigilance databases of FAERS and VigiBase.

Junyi Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.